[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576068":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":17,"locations":24,"responsibleParty":36,"collaborators":38,"id":42,"slug":7,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":7,"enrollmentInfo":51,"targetDuration":7,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",null,[9,13],{"name":10,"affiliation":11,"role":12},"Astrid Blom, MD","Dermato-oncology Department, Ambroise Paré Hospital, APHP","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":15,"role":16},"Yassine Taoufik, MD, PhD","U1186 INSERM, PAUL BROUSSE Hospital, APHP","STUDY_DIRECTOR",[18,22],{"name":10,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","+33 (01) 49 09 44 82","astrid.blom@aphp.fr",{"name":14,"role":19,"phone":7,"phoneExt":7,"email":23},"yassine.taoufik@aphp.fr",[25],{"facility":11,"status":26,"city":27,"state":7,"zip":28,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":7},"RECRUITING","Boulogne-Billancourt","92100","France",{"type":31,"coordinates":32},"Point",[33,34],2.24128,48.83545,{"lat":34,"lon":33},{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[39],{"name":40,"class":41},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV","100576068",false,"NCT06780475","Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma","Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Merkel Cell Carcinoma of Skin","VIRASKIN","Inclusion Criteria:\n\n* Patients \\>= 18 years old;\n* Diagnosed with Merkel cell carcinoma of skin, ongoing for local treatment, systemic treatment, complementary treatment or an active follow-up;\n* Informed for the study and no-opposed for participation;\n* Affiliated with a social security scheme or in an equivalent situation.\n\nExclusion Criteria:\n\n* Patients ongoing another interventional clinical trial;\n* Patients under guardianship or trusteeship;\n* Pregnancy or breastfeed;\n* Patients refusal.","ALL","18 Years",{"count":52,"type":53},15,"ESTIMATED","OBSERVATIONAL","The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.",[57],"Merkel Cell Carcinoma of Skin",[57],"2025-11-18",{"date":61,"type":62},"2025-11-19","ACTUAL",{"date":64,"type":62},"2025-05-27",{"date":66,"type":53},"2027-05",{"name":5,"class":6},1]